This study aims to broaden the reach of CONNECT, a program designed to encourage people who are having a lung cancer screening test to also quit smoking. CONNECT targets smokers who are undergoing lung cancer screening and includes an interactive Video Doctor which provides participants with information tailored to their individual responses as well as proactive outreach using brief telephone calls and text messaging to follow up and connect smokers with evidence-based resources for smoking cessation.
This study will develop versions in Spanish and Cantonese of CONNECT, and will offer additional proactive outreach and streamlined access to nicotine replacement therapy (NRT) including direct pharmacist furnishing. We will evaluate the impact of the revised CONNECT on smoking cessation outcomes.
Evaluating the Impact of CONNECT, a Novel Smoking Cessation Intervention, in a Diverse, Multi-lingual Population
In the first phase of the study, we will conduct focus groups and beta testing with English, Spanish and Cantonese speaking participants which will inform the cultural adaptation, fine tuning and updating of the CONNECT smoking cessation intervention.
In a randomized controlled trial, we will assess the impact of CONNECT on the outcomes of rates of smoking cessation at 6 months, cotinine verified 7-day smoking cessation and utilization of smoking cessation resources and pharmacotherapy in a diverse group of English, Spanish, and Cantonese speaking high-risk smokers who will be randomized to 1 of of 2 groups.
Group 1: Participants receive the CONNECT Multi-lingual intervention. The intervention consists of two components 1) multilingual CONNECT Video Doctor; and 2) Proactive Outreach.
Group 2: Participants receive usual care from their primary care provider.
Group 1 and 2 participants are followed up at 1-week, and 1, 3, and 6 months. At 6-months, participants will be asked to complete an at-home saliva kit to verify their smoking status.